.svg)
BLOG
The Latest on Solid IO
Solid IO Selected to Present at European DeepTech Week
Solid IO has been selected among the most promising European deep tech startups in biotech to present at European DeepTech Week in Paris in March 2026.
Solid IO Selected to Present at European DeepTech Week
Solid IO has been selected among the most promising European deep tech startups in biotech to present at European DeepTech Week in Paris in March 2026.
Solid IO receives Instrumentarium Science Foundation grant
Solid IO has been selected as one of three companies to receive a grant from the Instrumentarium Science Foundation.
Lee-Anne Zinetti joins Solid IO’s Advisors
We are pleased to welcome Lee-Anne as an advisor to Solid IO, supporting our work with pharmaceutical and biotechnology partners and the commercialization pathway of diagnostics.
Heidi Haikala selected as a Creative Innovator 2025
The Finnish Medical Society Duodecim has named Solid IO’s Chief Scientific Officer and co-founder, Heidi Haikala, among the Health Influencers 2025 in the Creative Innovators category, recognizing individuals who advance healthcare through scientifically grounded, practice-oriented innovation.
Brilliant minds backing Solid IO’s mission
We are proud to introduce our newest advisors, whose experience spans clinical diagnostics, pharma strategy, translational immuno-oncology, healthcare market dynamics and global commercialization.
Lung Cancer Awareness Month – Confronting the World’s Deadliest Cancer
November marks the international Lung Cancer Awareness Month. Lung cancer is the leading cause of cancer-related deaths worldwide, with more than two million new cases diagnosed each year.
Shape the future of cancer care
Join SolidIO in transforming cancer care with groundbreaking organ-on-chip technology. We’re calling on researchers, clinicians, and investors to partner with us in advancing precision medicine, accelerating innovation, and expanding global access to personalized oncology. Together, we can bring clarity and better outcomes to cancer care worldwide.